Cat. No.: DAB-0012270
Product Information | |
---|---|
Clonality | Monoclonal |
Isotype | IgG |
Host Species | Rabbit |
Reactivity | Mouse |
Applications | IF |
Product Description | Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of mouse Mfsd2a protein. |
Format | Liquid |
Purity | Affinity purity |
Target Information | |
---|---|
Target Name | Mfsd2a |
UniProt No. | Q9DA75 |
Gene ID | 76574 |
Gene Description | Mfsd2a is a sodium-dependent lysophosphatidylcholine symporter. It regulates lipid metabolism, growth and development, and motor function. It transports lysophosphatidylcholines consisting of omega-3 fatty acid docosahexaenoic acid or other long-chain fatty acids. Mfsd2a was shown to be critical for the brain to take up DHA from plasma. Furthermore, Mfsd2a is required for the blood-brain barrier formation and function. Lipids transported into endothelial cells in the central nervous system by Mfsd2a form a lipid environment essential to maintain BBB integrity. |
Shipping & Storage | |
---|---|
Shipping | Shipped at 4 °C. |
Storage Instructions | Store at –20 °C. Do not aliquot the antibody. |
Storage Buffer | Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.